Dana Hilt, MD, CMO
Frequency Therapeutics, Boston, MA
Expertise: Neurology, Neuroscience, Development of Therapeutics for CNS conditions, Early-stage Parkinson’s clinical trials, Neurotrophic factors in neurodegenerative diseases
Lysosomal Therapeutics, FORUM Pharma, Ascend Therapeutics, Guilford Pharma, Amgen, NIH

Geert Jan Groeneveld, Ph.D., MD, CMO/CSO
Centre for Human Drug Research (CHDR)
Professor of Clinical Neuropharmacology
Leiden University Medical Center, Leiden
Expertise: Neurology, Clinical pharmacology, Early-stage drug development for neurodegenerative disease and pain, gene therapy for Parkinson’s disease
Leiden University Medical Center, VU Medical Center, Genzyme Europe

Ken Marek, MD, Co-Founder, Institute for Neurodegenerative Disorders, New Haven, CT

Expertise: Neurology, Neuroscience. Development of biomarkers for early detection and assessment of progression of neurodegenerative disorders, in vivo neuroreceptor imaging for Parkinson’s disease
Parkinson’s Progression Markers Initiative Principal Investigator, SAB member, Michael J. Fox Foundation, Molecular Neuroimaging

Sudha Seshadri, MD, University of Texas Health, Founder and Director, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases San Antonio, Texas

Expertise: Neurology, Neurobiology of Aging and Alzheimer’s disease, Advanced treatment of Neurodegenerative diseases
BoMedical Center, All India Institute of Medical Sciences
Bouston University School of Medicine, Univ. of Massachusetts

Dr. Teus van Laar, Professor of Neurology (Advanced treatment of Parkinson's disease) Groningen University Medical Center, Groningen

Expertise: Advanced treatment of Parkinson's disease, Neurodegenerative diseases, Clinical pharmacology, Neuromodulation
Founder and Pres., Parkinson Platform Noord-Nederland, Member of Ethical Review Board, UMCG

Shahin Gharakhanian, MD; SG MD Consulting

Expertise: Clinical Trial Design, Development & Mngmt, Translational Medicine, Program Chair & Co-Founder, Boston Biotech Summit
Stallergenes Greer, Vertex Pharma, AP-HP Paris Univ Hospitals